Christine Milligan has greater than 25 years experience in early drug development; 13 years in developing drugs in CNS, pain and cardiovascular areas; 4 years in program management of CTX/IND submissions and latterly >10 years in managing clinical materials. Dr. Milligan has a PhD and MBA from University of Glasgow; honorary lectureships at University of Glasgow UK and University of Edinburgh UK in drug development. She has numerous papers and presentations to the scientific community. Dr. Milligan served as 2010 Chair and council member for international ISPE investigational products group.